Ferroptosis induction via targeting metabolic alterations in head and neck cancer

被引:8
|
作者
Lee, Jaewang [1 ,2 ]
Roh, Jong-Lyel [1 ,2 ]
机构
[1] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam 13496, Gyeonggi Do, South Korea
[2] CHA Univ, Gen Grad Sch, Dept Biomed Sci, Seongnam, South Korea
基金
新加坡国家研究基金会;
关键词
Metabolism; Mitochondria; Ferroptosis; Lipid peroxidation; Head and neck cancer; SQUAMOUS-CELL CARCINOMA; CISPLATIN-RESISTANT HEAD; NASOPHARYNGEAL CARCINOMA; LIPID DROPLETS; TUMOR-GROWTH; INHIBITION; IRON; DEATH; CELECOXIB; METASTASIS;
D O I
10.1016/j.critrevonc.2022.103887
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ferroptosis is a newly regulated cell death induced by the accumulation of iron-mediated lipid peroxidation. The alteration of cancer metabolism may contribute to proliferation, metastasis, and treatment resistance in human cancers, implicating the sensitivity to ferroptosis induction. Altered metabolism in cancer cells regulates oxidative stresses and changes metabolism intermediates, contributing to their deregulated growth and prolif-eration. Cancer metabolic changes toward the elevation of cellular free iron and polyunsaturated fatty acids sensitize cancer cells to lipid peroxidation toxicity tightly linked to ferroptosis. The altered metabolism in cancers can be served as a promising target to reverse cancer therapeutic resistance by ferroptosis induction to selectively kill cancer cells while sparing normal cells. The role of mitochondria and lipid metabolism in inducing ferroptosis in head and neck cancer (HNC) has been elucidated in previous studies. Ferroptosis is receiving attention in cancer research as treating cancers altering cellular metabolism and refractory from conventional therapies. More in-depth studies are needed to develop highly therapeutic drugs and practical methods to induce ferroptosis in diverse cancer cells and tumor microenvironments effectively. Therefore, this review intends to understand the altered metabolism and find new therapeutic possibilities using ferroptosis in HNC.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Targeting BRAF mutations in head and neck cancer
    Law, Chun Ho
    Chan, Franky Leung
    Lui, Vivian Wai Yan
    CANCER RESEARCH, 2023, 83 (07)
  • [32] Targeting the immune system in head and neck cancer
    de Castro, Gilberto, Jr.
    Isaacsson Velho, Pedro H.
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (03) : 157 - 158
  • [33] Induction Chemotherapy in Head and Neck Cancer Reply
    Beitler, Jonathan J.
    Cooper, Jay S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : E54 - E54
  • [34] Induction chemotherapy for squamous cancer of the head and neck
    Kies M.S.
    Current Oncology Reports, 2007, 9 (2) : 129 - 133
  • [35] Induction chemotherapy challenges for head and neck cancer
    Faivre, Sandrine
    Albert, Sebastien
    Raymond, Eric
    LANCET ONCOLOGY, 2013, 14 (03): : 188 - 189
  • [36] Induction Chemotherapy in the Management of Head and Neck Cancer
    Fury, Matthew G.
    Shah, Jatin P.
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (04) : 292 - 298
  • [37] Induction chemotherapy in patients with head and neck cancer
    Chaigneau, Loic
    Guardiola, Emmanuel
    N'Guyen, Thierry
    Dufresne, Armelle
    Stein, Ulrich
    Villanueva, Christian
    Thiery-Vuillemin, Antoine
    Lorchel, Fabrice
    Pivot, Xavier
    BULLETIN DU CANCER, 2006, 93 (07) : 677 - 682
  • [38] Metabolic Microscopy of Head and Neck Cancer Organoids
    Shah, Amy T.
    Skala, Melissa C.
    MULTIPHOTON MICROSCOPY IN THE BIOMEDICAL SCIENCES XVI, 2016, 9712
  • [39] Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters
    Mehibel, Manal
    Ortiz-Martinez, Fernando
    Voelxen, Nadine
    Boyers, Amy
    Chadwick, Amy
    Telfer, Brian A.
    Mueller-Klieser, Wolfgang
    West, Catharine M.
    Critchlow, Susan E.
    Williams, Kaye J.
    Stratford, Ian J.
    SCIENTIFIC REPORTS, 2018, 8
  • [40] Metabolic Imaging of Head and Neck Cancer Organoids
    Shah, Amy T.
    Heaster, Tiffany M.
    Skala, Melissa C.
    PLOS ONE, 2017, 12 (01):